Melox (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. By lowering prostaglandin levels at the site of injury, meloxicam diminishes swelling and discomfort.

The specific dose of Melox is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage adjustments are made individually, and patients should follow the prescriber’s instructions exactly.

Safety of meloxicam in pregnancy and lactation has not been fully established. It is generally avoided during the third trimester because of potential fetal cardiovascular effects, and breastfeeding mothers should consult their physician before use.

To request Melox, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Melox (meloxicam) offers a longer half‑life and greater COX‑2 selectivity compared with many traditional NSAIDs such as ibuprofen or naproxen. This can allow once‑daily dosing and may reduce gastrointestinal side effects, though cardiovascular and renal risks remain similar to other NSAIDs.

Melox should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Melox is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience stomach upset may benefit from taking it with meals. Swallow tablets whole; do not crush or chew unless instructed by a healthcare professional.

Serious risks include gastrointestinal ulceration or bleeding, cardiovascular events such as heart attack or stroke, severe skin reactions, liver injury, and acute kidney damage. Patients should be monitored for signs of these conditions, especially if they have pre‑existing risk factors.

Melox is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, patients with severe heart failure, and anyone who has had a recent coronary artery bypass graft. It should also be avoided in late pregnancy.